Leukotriene Inhibition in Hamster Periodontitis. A Histochemical and Morphometric Study

Overview

Journal Mediators Inflamm

Publisher Wiley

Specialties Biochemistry
Pathology

Date 1992 Jan 1

PMID 18475481

Citations 1

Authors

B Baroukh

J L Saffar

Affiliations

Soon will be listed here.

Abstract

The effects of leukotriene (LT) inhibition on gingival and adjacent bone compartments were assessed by using phenidone (100 mg/kg/d) and ketoconazole (50 mg/kg/d) given for 4 weeks to periodontitis-affected hamsters. In the gingiva the two agents significantly decreased PMNL recruitment and migration and increased the vascular lumen. At the bone level, they reduced significantly preosteoclast and osteoclast numbers but did not affect osteoclast activity. Phenidone had no action on periodontitis induced inhibition of bone formation; in contrast ketoconazole enhanced formation. As both phenidone and ketoconazole are unspecific LT inhibitors it cannot be ascertained that the effects observed were actually due to LT inhibition. However, phenidone and ketoconazole induced changes different from indomethacin used in previous studies to inhibit the cyclooxygenase pathway. These discrepancies suggest that LT inhibition occurred in the present study and that they participate in gingival inflammation and osteoclastic destruction during hamster periodontitis.

Citing Articles

Regulation of inflammation by lipid mediators in oral diseases.

Sommakia S, Baker O Oral Dis. 2016; 23(5):576-597.

PMID: 27426637 PMC: 5243936. DOI: 10.1111/odi.12544.

References

Snyder D, Fleisch J . Leukotriene receptor antagonists as potential therapeutic agents. Annu Rev Pharmacol Toxicol. 1989; 29:123-43. DOI: 10.1146/annurev.pa.29.040189.001011. View

Dersot J, Saffar J . Periodontal and femoral bone status in periodontitis-affected hamsters receiving a high dose indomethacin treatment. J Biol Buccale. 1989; 17(2):93-101. View

Tatsuno I, Saito H, Chang K, Tamura Y, Yoshida S . Comparison of the effect between leukotriene B4 and leukotriene B5 on the induction of interleukin 1-like activity and calcium mobilizing activity in human blood monocytes. Agents Actions. 1990; 29(3-4):324-7. DOI: 10.1007/BF01966464. View

Nolan K, Keagy B, Ramadan F, JOHNSON Jr G, Henke D . Endothelial cells can synthesize leukotriene B4. J Vasc Surg. 1990; 12(3):298-304. View

Dunham B, Hechtman H, Valeri C, Shepro D . Antiinflammatory agents inhibit microvascular permeability induced by leukotrienes and by stimulated human neutrophils. Microcirc Endothelium Lymphatics. 1984; 1(4):465-89. View

Carlson R, Chang J, Lewis A . Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agents. Agents Actions. 1985; 17(2):197-204. DOI: 10.1007/BF01966592. View

McMillan R, Foster S . Leukotriene B4 and inflammatory disease. Agents Actions. 1988; 24(1-2):114-9. DOI: 10.1007/BF01968088. View

Reinhardt T, Horst R . Ketoconazole inhibits self-induced metabolism of 1,25-dihydroxyvitamin D3 and amplifies 1,25-dihydroxyvitamin D3 receptor up-regulation in rat osteosarcoma cells. Arch Biochem Biophys. 1989; 272(2):459-65. DOI: 10.1016/0003-9861(89)90240-3. View

Sandy J, Meikle M, Martin B, Farndale R . Leukotriene B4 increases intracellular calcium concentration and phosphoinositide metabolism in mouse osteoblasts via cyclic adenosine 3',5'-monophosphate-independent pathways. Endocrinology. 1991; 129(2):582-90. DOI: 10.1210/endo-129-2-582. View

10.

Meghji S, Sandy J, Scutt A, Harvey W, Harris M . Stimulation of bone resorption by lipoxygenase metabolites of arachidonic acid. Prostaglandins. 1988; 36(2):139-49. DOI: 10.1016/0090-6980(88)90301-2. View

11.

Makris G, Saffar J . Disturbances in bone remodeling during the progress of hamster periodontitis. A morphological and quantitative study. J Periodontal Res. 1985; 20(4):411-20. DOI: 10.1111/j.1600-0765.1985.tb00453.x. View

12.

Ward P, Marks R . The acute inflammatory reaction. Curr Opin Immunol. 1989; 2(1):5-9. DOI: 10.1016/0952-7915(89)90090-3. View

13.

Moser R, Schleiffenbaum B, Groscurth P, Fehr J . Interleukin 1 and tumor necrosis factor stimulate human vascular endothelial cells to promote transendothelial neutrophil passage. J Clin Invest. 1989; 83(2):444-55. PMC: 303700. DOI: 10.1172/JCI113903. View

14.

Elattar T, Lin H, Killoy W, Vanderhoek J, Goodson J . Hydroxy fatty acids and prostaglandin formation in diseased human periodontal pocket tissue. J Periodontal Res. 1986; 21(2):169-76. DOI: 10.1111/j.1600-0765.1986.tb01449.x. View

15.

Palder S, Huval W, Lelcuk S, Alexander F, Shepro D, Mannick J . Reduction of polymorphonuclear leukocyte accumulations by inhibition of cyclooxygenase and thromboxane syntase in the rabbit. Surgery. 1986; 99(1):72-81. View

16.

Blackwell G, Flower R . 1-phenyl-3-pyrazolidone: an inhibitor of cyclo-oxygenase and lipoxygenase pathways in lung and platelets. Prostaglandins. 1978; 16(3):417-25. DOI: 10.1016/0090-6980(78)90220-4. View

17.

Dahlen S, Bjork J, Hedqvist P, Arfors K, Hammarstrom S, Lindgren J . Leukotrienes promote plasma leakage and leukocyte adhesion in postcapillary venules: in vivo effects with relevance to the acute inflammatory response. Proc Natl Acad Sci U S A. 1981; 78(6):3887-91. PMC: 319678. DOI: 10.1073/pnas.78.6.3887. View

18.

Ford-Hutchinson A, Bray M, Doig M, Shipley M, Smith M . Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes. Nature. 1980; 286(5770):264-5. DOI: 10.1038/286264a0. View

19.

Beetens J, Loots W, Somers Y, Coene M, de Clerck F . Ketoconazole inhibits the biosynthesis of leukotrienes in vitro and in vivo. Biochem Pharmacol. 1986; 35(6):883-91. DOI: 10.1016/0006-2952(86)90072-9. View

20.

Fels A, Pawlowski N, Cramer E, King T, COHN Z, Scott W . Human alveolar macrophages produce leukotriene B4. Proc Natl Acad Sci U S A. 1982; 79(24):7866-70. PMC: 347450. DOI: 10.1073/pnas.79.24.7866. View